{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:41:16Z","timestamp":1772271676606,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.nic.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T05:41:30Z","timestamp":1715665290000},"page":"317-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases"],"prefix":"10.1016","volume":"34","author":[{"given":"Anthony","family":"Traboulsee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.B.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib1","article-title":"Diagnosis of multiple sclerosis: 2017 revisions to the McDonald diagnostic criteria for multiple sclerosis","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.38.10.1511","article-title":"Multiple sclerosis: a serial study using MRI in relapsing patients","volume":"38","author":"Isaac","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2017.08.014","article-title":"Common clinical and imaging conditions misdiagnosed as multiple sclerosis: a current approach to the differential diagnosis of multiple sclerosis","volume":"36","author":"Siva","year":"2018","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib4","first-page":"455","article-title":"Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines","volume":"27","author":"Simon","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nic.2008.09.005","article-title":"Spinal-Cord MRI in multiple sclerosis: conventional and nonconventional mr techniques","volume":"19","author":"Bot","year":"2009","journal-title":"Neuroimaging Clin N Am"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00234-009-0512-0","article-title":"High field MRI in the diagnosis of multiple sclerosis: High field-high yield?","volume":"51","author":"Wattjes","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nic.2024.03.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103101","article-title":"Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions","volume":"35","author":"Arnold","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"12","key":"10.1016\/j.nic.2024.03.002_bib11","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.3174\/ajnr.A4943","article-title":"Addressing concerns regarding the use of gadolinium in a standardized mri protocol for the diagnosis and follow-up of multiple sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"Am J Neuroradiol"},{"issue":"7","key":"10.1016\/j.nic.2024.03.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.nic.2024.03.002_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.nic.2024.03.002_bib14","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon Beta-1A therapy initiated during a first\u00a0demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9268","key":"10.1016\/j.nic.2024.03.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.nic.2024.03.002_bib16","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P","volume":"46","author":"Li","year":"1999","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab419","article-title":"The neuroradiology of progressive multifocal leukoencephalopathy: A clinical trial perspective","volume":"145","author":"Baldassari","year":"2022","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.nic.2024.03.002_bib19","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A6547","article-title":"Value of 3T susceptibility-weighted imaging in the diagnosis of multiple sclerosis","volume":"41","author":"Clarke","year":"2020","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"10.1016\/j.nic.2024.03.002_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrneurol.2016.166","article-title":"The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative","volume":"12","author":"Sati","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib21","article-title":"Slowly expanding lesions predict 9-year multiple sclerosis disease progression","volume":"9","author":"Preziosa","year":"2022","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2024.03.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102834","article-title":"Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial","volume":"32","author":"Ontaneda","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.12120208","article-title":"FLAIR\u2217: A combined MR contrast technique for visualizing white matter lesions and parenchymal veins","volume":"265","author":"Sati","year":"2012","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-020-0314-x","article-title":"MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice","volume":"16","author":"Sastre-Garriga","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.64.10.1416","article-title":"Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis","volume":"64","author":"Calabrese","year":"2007","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab033","article-title":"Cortical involvement determines impairment 30 years after a clinically isolated syndrome","volume":"144","author":"Haider","year":"2021","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aws246","article-title":"Cortical lesion load associates with progression of disability in multiple sclerosis","volume":"135","author":"Calabrese","year":"2012","journal-title":"Brain"},{"issue":"24","key":"10.1016\/j.nic.2024.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005685","article-title":"The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis","volume":"90","author":"Scalfari","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nic.2024.03.002_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"B\u00f8","year":"2003","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib31","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e31820a0cc4","article-title":"Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI","volume":"76","author":"Geurts","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nic.2024.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-303023","article-title":"Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI","volume":"83","author":"Sethi","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nic.2024.03.002_bib33","article-title":"Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis","author":"Cagol","year":"2023","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A4514","article-title":"FLAIR2: A combination of FLAIR and T2 for improved MS lesion detection","volume":"37","author":"Wiggermann","year":"2016","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib36","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J\u00a0Neuroradiol"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib37","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207507","article-title":"Diagnostic performance of adding the optic nerve region assessed by optical coherence tomography to the diagnostic criteria for multiple sclerosis","volume":"101","author":"Bsteh","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib38","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207805","article-title":"Adding the optic nerve in multiple sclerosis diagnostic criteria","volume":"102","author":"Vidal-Jordana","year":"2024","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib39","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011339","article-title":"Optic nerve topography in multiple sclerosis diagnosis","volume":"96","author":"Vidal-Jordana","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/WNL.46.2.373","article-title":"Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis","volume":"46","author":"Thorpe","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nic.2024.03.002_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/1352458515599246","article-title":"Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis","volume":"22","author":"Zecca","year":"2016","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A1485","article-title":"Spinal dural arteriovenous fistulas","volume":"30","author":"Krings","year":"2009","journal-title":"Am J Neuroradiol"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2023.2221027","article-title":"Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world","volume":"22","author":"Dsilva","year":"2023","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/jnnp-2015-311411","article-title":"MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS","volume":"87","author":"Wattjes","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-318261","article-title":"Performance of PML diagnostic criteria in natalizumab-associated PML: data from the dutch-belgian cohort","volume":"90","author":"Wijburg","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.nic.2024.03.002_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jnnp-2014-308630","article-title":"MRI pattern in asymptomatic natalizumab-associated PML","volume":"86","author":"Wattjes","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp-2016-313772","article-title":"MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance","volume":"87","author":"Wijburg","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acn3.114","article-title":"Outcome and survival of asymptomatic PML in natalizumab-treated MS patients","volume":"1","author":"Dong-Si","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1352458519854162","article-title":"Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debate","volume":"26","author":"Scarpazza","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.nic.2024.03.002_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102842","article-title":"Reduction of the risk of PML in natalizumab treated MS patients in Sweden: An effect of improved PML risk surveillance","volume":"50","author":"K\u00e5gstr\u00f6m","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp-2017-316886","article-title":"Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS","volume":"89","author":"Wattjes","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.nic.2024.03.002_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s00234-023-03189-8","article-title":"Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses","volume":"65","author":"van Nederpelt","year":"2023","journal-title":"Neuroradiology"},{"issue":"14","key":"10.1016\/j.nic.2024.03.002_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Multiple Sclerosis Journal"},{"issue":"9","key":"10.1016\/j.nic.2024.03.002_bib54","article-title":"Patterning chronic active demyelination in slowly expanding\/evolving white matter MS lesions","volume":"41","author":"Elliott","year":"2020","journal-title":"Am J Neuroradiol"},{"issue":"17","key":"10.1016\/j.nic.2024.03.002_bib55","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200144","article-title":"Association of slowly expanding lesions on mri with disability in people with secondary progressive multiple sclerosis","volume":"98","author":"Calvi","year":"2022","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nic.2024.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in\u00a0vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab134","article-title":"Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression","volume":"3","author":"Treaba","year":"2021","journal-title":"Brain Commun"},{"issue":"13","key":"10.1016\/j.nic.2024.03.002_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/13524585221102921","article-title":"Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study","volume":"28","author":"Hemond","year":"2022","journal-title":"Multiple Sclerosis Journal"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib59","doi-asserted-by":"crossref","DOI":"10.1586\/14737175.7.3.271","article-title":"Gray and normal-appearing white matter in multiple sclerosis: An MRI perspective","volume":"7","author":"Vrenken","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib60","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.59.1.126","article-title":"Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS","volume":"59","author":"Traboulsee","year":"2002","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/08465371211015657","article-title":"Canadian association of radiologists recommendations for the safe use of MRI during pregnancy","volume":"73","author":"Jabehdar Maralani","year":"2022","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib63","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020191550","article-title":"Specific absorption rate and specific energy dose: Comparison of 1.5-T versus 3.0-T fetal MRI","volume":"295","author":"Barrera","year":"2020","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.nic.2024.03.002_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"JAMA, J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib65","article-title":"Is administration of gadolinium-based contrast media to pregnant women and small children justified?","volume":"34","author":"Sundgren","year":"2011","journal-title":"J\u00a0Magn Reson Imag"},{"key":"10.1016\/j.nic.2024.03.002_bib66","unstructured":"Contrast Media Safety Committee. ESUR Guidelines on Contrast Agents v10.0. European Society of Urogenital Radiology. Published online 2018."},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2352-4642(18)30026-9","article-title":"MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study","volume":"2","author":"Fadda","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0883073812443006","article-title":"Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program","volume":"28","author":"O\u2019Mahony","year":"2013","journal-title":"J\u00a0Child Neurol"},{"issue":"14","key":"10.1016\/j.nic.2024.03.002_bib69","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182a6cb9b","article-title":"Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials","volume":"81","author":"Verhey","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib70","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000000262","article-title":"Incidence of meningeal enhancement on brain MRI secondary to lumbar puncture","volume":"6","author":"Wesley","year":"2016","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"10.1016\/j.nic.2024.03.002_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12667","article-title":"Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society","volume":"135","author":"V\u00e5gberg","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nic.2024.03.002_bib72","article-title":"Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations","volume":"1","author":"Arnold","year":"2015","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0317167100014244","article-title":"Treatment optimization in MS: Canadian MS Working Group updated recommendations","volume":"40","author":"Freedman","year":"2013","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib74","doi-asserted-by":"crossref","DOI":"10.1017\/cjn.2020.66","article-title":"Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations","volume":"47","author":"Freedman","year":"2020","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1016\/j.nic.2024.03.002_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/cjn.2015.24","article-title":"Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring","volume":"42","author":"Traboulsee","year":"2015","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.nic.2024.03.002_bib76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.nic.2024.03.002_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/135245859600100610","article-title":"Guidelines for MRI monitoring of the treatment of multiple sclerosis: Recommendations of the\u00a0US Multiple Sclerosis Society\u2019s task force","volume":"1","author":"Miller","year":"1996","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.nic.2024.03.002_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.pjnns.2018.09.010","article-title":"Guidelines of the Polish Medical Society of radiology for the routinely used MRI protocol in patients with multiple sclerosis","volume":"52","author":"S\u0105siadek","year":"2018","journal-title":"Neurol Neurochir Pol"},{"issue":"6","key":"10.1016\/j.nic.2024.03.002_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/1754-9485.12000","article-title":"Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study","volume":"56","author":"Curley","year":"2012","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"issue":"5","key":"10.1016\/j.nic.2024.03.002_bib80","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7224\/1537-2073.2020-094","article-title":"An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis","volume":"22","author":"Saslow","year":"2020","journal-title":"Int J MS Care"},{"issue":"8","key":"10.1016\/j.nic.2024.03.002_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11081310","article-title":"Walk your talk: Real-world adherence to guidelines on the use of MRI in multiple sclerosis","volume":"11","author":"Tortora","year":"2021","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.nic.2024.03.002_bib82","article-title":"Adherence to MRI Protocol Consensus Guidelines in Multiple Sclerosis Patients at Taif Hospitals","volume":"8","author":"Alamri","year":"2020","journal-title":"Int J Med Imag"},{"key":"10.1016\/j.nic.2024.03.002_bib83","series-title":"Scientific and educational competitions judging committee, ed. Canadian association of radiologists 2023 annual meeting","article-title":"Progressive steps towards implementation of a standardized MRI protocol to improve care for people with MS in British Columbia","author":"Li","year":"2023"},{"key":"10.1016\/j.nic.2024.03.002_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110505","article-title":"Kulanthaivelu and colleagues: Comparison of 3D Double Inversion Recovery (DIR) versus 3D Fluid Attenuated Inversion Recovery (FLAIR) in precise diagnosis of acute optic neuritis","volume":"155","author":"Murumkar","year":"2022","journal-title":"Eur J Radiol"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514924000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514924000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T20:02:37Z","timestamp":1719432157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514924000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1052514924000224"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2024.03.002","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}